Free Trial

AEON Biopharma (AEON) Short Interest Ratio & Short Volume

AEON Biopharma logo
$0.82 +0.09 (+11.67%)
Closing price 03:58 PM Eastern
Extended Trading
$0.82 +0.00 (+0.25%)
As of 06:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AEON Biopharma Short Interest Data

AEON Biopharma (AEON) has a short interest of 176,600 shares, representing 1.67% of the float (the number of shares available for trading by the public). This marks a 156.31% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 1.00 million shares to cover all short positions.

Current Short Interest
176,600 shares
Previous Short Interest
68,900 shares
Change Vs. Previous Month
+156.31%
Dollar Volume Sold Short
$87.08 thousand
Short Interest Ratio
0.1 Days to Cover
Last Record Date
May 15, 2025
Outstanding Shares
11,305,000 shares
Float Size
10,560,000 shares
Short Percent of Float
1.67%
Today's Trading Volume
643,959 shares
Average Trading Volume
1,001,692 shares
Today's Volume Vs. Average
64%
Short Selling AEON Biopharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for AEON Biopharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

AEON Short Interest Over Time

AEON Days to Cover Over Time

AEON Percentage of Float Shorted Over Time

AEON Biopharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/2025176,600 shares $87.08 thousand +156.3%1.7%0.1 $0.49
4/30/202568,900 shares $29.83 thousand -81.4%0.9%0 $0.43
4/15/2025371,100 shares $151.04 thousand +76.6%4.8%0.1 $0.41
3/14/2025174,000 shares $115.10 thousand -55.8%21.5%0.1 $0.66
2/28/2025393,200 shares $294.90 thousand +962.7%51.8%0.1 $0.75
2/14/202537,000 shares $343.66 thousand -98.8%4.9%0.2 $9.29
1/31/20252,980,000 shares $27.61 million +150.4%6.3%0.2 $9.27
1/15/20251,190,000 shares $9.39 million +1,847.6%2.5%0.1 $7.89

AEON Short Interest - Frequently Asked Questions

What is AEON Biopharma's current short interest?

Short interest is the volume of AEON Biopharma shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 176,600 shares of AEON short. 1.67% of AEON Biopharma's shares are currently sold short. Learn More on AEON Biopharma's current short interest.

What is a good short interest percentage for AEON Biopharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.67% of AEON Biopharma's floating shares are currently sold short.

Is AEON Biopharma's short interest increasing or decreasing?

AEON Biopharma saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 176,600 shares, an increase of 156.3% from the previous total of 68,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is AEON Biopharma's float size?

AEON Biopharma currently has issued a total of 11,305,000 shares. Some of AEON Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AEON Biopharma currently has a public float of 10,560,000 shares.

How does AEON Biopharma's short interest compare to its competitors?

1.67% of AEON Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to AEON Biopharma: NanoViricides, Inc. (0.44%), Tempest Therapeutics, Inc. (3.80%), Cara Therapeutics, Inc. (1.74%), Cyclo Therapeutics, Inc. (3.55%), Lisata Therapeutics, Inc. (0.35%), MIRA Pharmaceuticals, Inc. (3.63%), Relmada Therapeutics, Inc. (4.93%), NeuroSense Therapeutics Ltd. (1.67%), CASI Pharmaceuticals, Inc. (0.31%), CalciMedica, Inc. (2.05%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

What does it mean to sell short AEON Biopharma stock?

Short selling AEON is an investing strategy that aims to generate trading profit from AEON Biopharma as its price is falling. AEON shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against AEON Biopharma?

A short squeeze for AEON Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AEON, which in turn drives the price of the stock up even further.

How often is AEON Biopharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AEON, twice per month. The most recent reporting period available is May, 15 2025.




This page (NASDAQ:AEON) was last updated on 6/6/2025 by MarketBeat.com Staff
From Our Partners